Drugs / Follistatin plasmid
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06411366 | Aug 2022 → Aug 2023 | — | Minicircle | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Follistatin plasmid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06411366 ↗ |